Timothy F. Osborne

Timothy F. Osborne

Auto-generated profile, based on publicly available information

Timothy F. Osborne

Johns Hopkins

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JLJae-Ho Lee
Jae-Ho Lee
PPPeter Phelan
Peter Phelan
MSMinsang Shin
Minsang Shin
Byungchul OhByungchul Oh
Byungchul Oh
XHXianlin Han
Xianlin Han
TOTimothy F. Osborne
Timothy F. Osborne
Significance: There is a growing appreciation for a fundamental connection between lipid metabolism and the innate immune response. Phagocytosis is a key macrophage innate immune response to pathogen exposure, and cytoplasmic membrane expansion is required to surround and capture the target pathogen prior to internalization. Sterol regulatory element binding proteins (SREBPs) are gene regulatory factors that sense the intracellular lipid environment and modulate key genes that drive fatty acid and cholesterol synthesis to maintain lipid homeostasis. In this study, we show that, in mutant cells that lack a key SREBP isoform, phagocytosis is impaired, and we track the defect to altered lipid composition of membrane phospholipids that results in decreased interaction between membrane lipid rafts and the actin cytoskeletal network.

3 February 2020 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
JLJae-Ho Lee
Jae-Ho Lee
YGYounghoon Go
Younghoon Go
DKDo-Young Kim
Do-Young Kim
SLSun Hee Lee
Sun Hee Lee
OKOk-Hee Kim
Ok-Hee Kim
Seung-Soon ImSeung-Soon Im
Seung-Soon Im
Isocitrate dehydrogenase 2 (IDH2) is an NADP+-dependent enzyme that catalyzes the oxidative decarboxylation of isocitrate to α-ketoglutarate in the mitochondrial matrix, and is critical for the production of NADPH to limit the accumulation of mitochondrial reactive oxygen species (ROS). Here, we showed that high-fat diet (HFD) feeding resulted in accelerated weight gain in the IDH2KO mice due to a reduction in whole-body energy expenditure. Moreover, the levels of NADP+, NADPH, NAD+, and NADH were significantly decreased in the brown adipose tissue (BAT) of the HFD-fed IDH2KO animals, accompanied by decreased mitochondrial function and reduced expression of key genes involved in mitochondrial biogenesis, energy expenditure, and ROS resolution. Interestingly, these changes were partially reversed when the antioxidant butylated hydroxyanisole was added to the HFD. These observations reveal a crucial role for IDH2 in limiting ROS-dependent mitochondrial damage when BAT metabolism is normally enhanced to limit weight gain in response to dietary caloric overload.

22 October 2020 in Cell Chemical Biology
Verified
Journal Article
Closed access
RERyan M. Esquejo
Ryan M. Esquejo
MRManuel Roqueta-Rivera
Manuel Roqueta-Rivera
WSWei Shao
Wei Shao
PPPeter E. Phelan
Peter E. Phelan
USUthpala Seneviratne
Uthpala Seneviratne
TOTimothy F. Osborne
Timothy F. Osborne

13 December 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
YMYu Muta
Yu Muta
JLJuan F. Linares
Juan F. Linares
AMAnxo Martinez-OrdoñeZ
Anxo Martinez-OrdoñeZ
ADAngeles Duran
Angeles Duran
TCTania Cid-Diaz
Tania Cid-Diaz
JMJorge Moscat
Jorge Moscat
The metabolic and signaling pathways regulating aggressive mesenchymal colorectal cancer (CRC) initiation and progression through the serrated route are largely unknown. Although relatively well characterized as BRAF mutant cancers, their poor response to current targeted therapy, difficult preneoplastic detection, and challenging endoscopic resection make the identification of their metabolic requirements a priority. Here, we demonstrate that the phosphorylation of SCAP by the atypical PKC (aPKC), PKCλ/ι promotes its degradation and inhibits the processing and activation of SREBP2, the master regulator of cholesterol biosynthesis. We show that the upregulation of SREBP2 and cholesterol by reduced aPKC levels is essential for controlling metaplasia and generating the most aggressive cell subpopulation in serrated tumors in mice and humans. Since these alterations are also detected prior to neoplastic transformation, together with the sensitivity of these tumors to cholesterol metabolism inhibitors, our data indicate that targeting cholesterol biosynthesis is a potential mechanism for serrated chemoprevention.

22 June 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
XZXinbo Zhang
Xinbo Zhang
JSJonathan Sun
Jonathan Sun
ACAlberto Canfran-Duque
Alberto Canfran-Duque
BABinod Aryal
Binod Aryal
GTGeorge Tellides
George Tellides
CFCarlos Fernández
Carlos Fernández
Epigenetic modifications of the genome, including DNA methylation, histone methylation/acetylation, and noncoding RNAs, have been reported to play a fundamental role in regulating immune response during the progression of atherosclerosis. SETDB2 is a member of the KMT1 family of lysine methyltransferases, and members of this family typically methylate histone H3 Lys9 (H3K9), an epigenetic mark associated with gene silencing. Previous studies have shown that SETDB2 is involved in innate and adaptive immunity, the proinflammatory response, and hepatic lipid metabolism. Here, we report that expression of SETDB2 is markedly upregulated in human and murine atherosclerotic lesions. Upregulation of SETDB2 was observed in proinflammatory M1 but not antiinflammatory M2 macrophages. Notably, we found that genetic deletion of SETDB2 in hematopoietic cells promoted vascular inflammation and enhanced the progression of atherosclerosis in BM transfer studies in Ldlr- knockout mice. Single-cell RNA-Seq analysis in isolated CD45 + cells from atherosclerotic plaques from mice transplanted with SETDB2-deficient BM revealed a significant increase in monocyte population and enhanced expression of genes involved in inflammation and myeloid cell recruitment. Additionally, we found that loss of SETDB2 in hematopoietic cells was associated with macrophage accumulation in atherosclerotic lesions and attenuated efferocytosis. Overall, these studies identify SETDB2 as an important inflammatory cell regulator that controls macrophage activation in atherosclerotic plaques.

16 April 2024 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
ELEun-Ho Lee
Eun-Ho Lee
JLJae-Ho Lee
Jae-Ho Lee
DKDo-Young Kim
Do-Young Kim
YLYoung-Seung Lee
Young-Seung Lee
YJYunju Jo
Yunju Jo
Seung-Soon ImSeung-Soon Im
Seung-Soon Im
Sterol regulatory element-binding protein (SREBP)-1c is involved in cellular lipid homeostasis and cholesterol biosynthesis and is highly increased in nonalcoholic steatohepatitis (NASH). However, the molecular mechanism by which SREBP-1c regulates hepatic stellate cells (HSCs) activation in NASH animal models and patients have not been fully elucidated. In this study, we examined the role of SREBP-1c in NASH and the regulation of LCN2 gene expression. Wild-type and SREBP-1c knockout (1cKO) mice were fed a high-fat/high-sucrose diet, treated with carbon tetrachloride (CCl4), and subjected to lipocalin-2 (LCN2) overexpression. The role of LCN2 in NASH progression was assessed using mouse primary hepatocytes, Kupffer cells, and HSCs. LCN2 expression was examined in samples from normal patients and those with NASH. LCN2 gene expression and secretion increased in CCl4-induced liver fibrosis mice model, and SREBP-1c regulated LCN2 gene transcription. Moreover, treatment with holo-LCN2 stimulated intracellular iron accumulation and fibrosis-related gene expression in mouse primary HSCs, but these effects were not observed in 1cKO HSCs, indicating that SREBP-1c-induced LCN2 expression and secretion could stimulate HSCs activation through iron accumulation. Furthermore, LCN2 expression was strongly correlated with inflammation and fibrosis in patients with NASH. Our findings indicate that SREBP-1c regulates Lcn2 gene expression, contributing to diet-induced NASH. Reduced Lcn2 expression in 1cKO mice protects against NASH development. Therefore, the activation of Lcn2 by SREBP-1c establishes a new connection between iron and lipid metabolism, affecting inflammation and HSCs activation. These findings may lead to new therapeutic strategies for NASH.